Prior authorization friction arrives quietly: a fax that needs resending, a status call that goes unanswered, a clinical note buried in a stack of paperwork. By the time a provider's office realizes how much time they're losing, patients have already started dropping off. Every manual touchpoint in the PA workflow adds latency to the prescribing process, and that latency compounds in ways that most practices underestimate until they're watching first-fill rates decline.

The good news is that most of the friction embedded in a modern PA workflow isn't structural, it's operational. Payer rules, clinical criteria, and medical necessity requirements aren't going away. But the fax steps, status calls, manual data re-entry, and denial follow-up loops that wrap around those requirements? That's waste. The good news is that it's removable.

Why Prior Authorization Friction Matters More Than You Think

Most providers know PA is painful. What's harder to see is exactly how much that pain is costing their practice, and their patients, in measurable, concrete terms.

Prior authorization was designed as a cost-control tool for payers, but it has become one of the most significant administrative burdens in U.S. healthcare. According to JAMA Network research on administrative costs in healthcare, administrative tasks consume nearly 25% of total healthcare spending in the United States. A substantial share of that burden falls directly on provider offices managing authorization requests.

The problem is how much manual process has accumulated around PA. Every time a clinical note has to be re-faxed, every time a staff member calls a payer to ask "did you receive our submission," every time a denial letter triggers a fresh round of documentation; that's time your team isn't spending on patient care.

The Hidden Cost of Friction: What Practices Miss on the P&L

Most practices don't have a line item called "PA friction cost." They have staff hours, they have overtime, they have patient calls about delayed prescriptions. The connection between those costs and the PA workflow often goes unmeasured.

AMA's 2024 prior authorization survey found that practices spend approximately 2 business days a week on PA-related tasks, with the average practice completing 45 prior authorizations per physician every week. This is time dedicated to a process that generates zero clinical value. It only exists to satisfy payer administrative requirements.

How Prescription Abandonment Connects to PA Delays

The downstream effect of PA friction isn't just slower approvals; it's patients who never fill their prescriptions at all. Research estimates that 20-30% of new prescriptions are never filled, and a meaningful portion of those abandoned prescriptions can be traced directly to coverage uncertainty and prior authorization delays.

When a patient leaves their appointment not knowing whether their medication will be approved, and they don't hear back within a day or two, they often don't follow up. They move on, find alternatives, or simply go without. The provider doesn't always know why the patient didn't fill and the connection between a slow PA workflow and lost patient outcomes rarely surfaces in practice data.

What Is Prior Authorization Friction, Exactly?

Prior authorization friction refers to every manual touchpoint, redundant step, and process gap in the PA workflow that adds time and effort without adding clinical or administrative value. It's distinct from the PA requirement itself; the underlying clinical review that payers conduct to assess medical necessity.

Think of it like the difference between a toll bridge and the traffic jam approaching it. The toll is structural, it's required by the entity that owns the bridge. The traffic jam is operational, it's the result of outdated infrastructure around the toll. PA friction is the traffic jam.

Structural Friction vs. Operational Friction

Understanding this distinction is critical for any practice looking to reduce PA burden, because the two types of friction require completely different responses.

Structural friction includes:

• Payer medical necessity criteria: coverage rules that vary by plan, formulary tier, and therapeutic area
  
  

• Step therapy requirements: payer mandates that patients try lower-cost alternatives before a preferred therapy is authorized
  
  

• Clinical documentation requirements: diagnosis codes, lab values, and prior treatment history that payers require to process the request
  
  

• Turnaround time windows: federal and state regulations that govern how quickly payers must respond

No amount of automation removes structural friction. A payer that requires documentation of prior therapy failure is still going to require that documentation regardless of how sophisticated your submission system is. Providers and technology vendors who claim otherwise are overpromising.

Operational friction, on the other hand, includes everything that wraps around those structural requirements:

• Manual data re-entry: copying information from an EHR into a payer form that already exists in the system
  
  

• Fax-based submissions: sending physical documents when electronic PA (ePA) rails exist but aren't being used
  
  

• Status chasing: calling payer lines to find out whether a submission was received and is being processed
  
  

• Unstructured denial follow-up: receiving a denial letter with no clear path forward and having to manually reconstruct the appeal
  
  

• Siloed communication: providers not knowing the PA status without leaving their EHR to check a separate portal

This is where automation makes its impact. Not by bypassing payer requirements, but by eliminating the surrounding waste.

Mapping the PA Journey: Where Friction Accumulates Stage by Stage

The PA process has five major stages, and each one carries its own friction profile. Understanding where delays stack up, and why, is the first step toward eliminating them.

Stage 1: Initiation - The Friction Begins Before You Submit

The moment a provider decides to prescribe a medication that requires prior authorization, the clock starts. But so does the friction. Before a single form is filled out, the office needs to determine: Does this plan require PA for this drug? What are the criteria? Which form do we need?

In a high-friction environment, that question is answered by a staff member who knows from experience, or who has to call the payer, or who looks it up in a fragmented reference document that may or may not be current. Research in The American Journal of Managed Care and related surveys shows that PA requirements and communication issues substantially increase administrative workload and reduce time available for direct patient care, contributing to provider work-arounds and inefficiencies.

In a low-friction environment, benefit verification is triggered automatically at the point of prescribing: pulling coverage, PA requirement status, and out-of-pocket cost information directly into the EHR before the provider even submits the prescription.

Stage 2: Clinical Data Gathering - The Most Labor-Intensive Step

Once the need for PA is confirmed, the office must collect the clinical evidence the payer requires: diagnosis codes, lab results, treatment history, clinical notes. This is where operational friction is highest, because in most practices, this information exists in the EHR but has to be manually located, reviewed, and transcribed into the authorization form.

A staff member typically has to open the clinical notes, identify the relevant evidence, and either summarize it into the PA form fields or attach documentation. If the form requires a specific ICD-10 code that differs from the provider's default coding, that has to be reconciled manually. If the payer wants proof of step therapy failure, that has to be pulled from visit history and formatted appropriately.

Stage 3: Submission - The Fax Problem

This is the step most practices are already aware of as a pain point. Fax-based PA submission is still widespread in the United States, even as CMS interoperability and prior authorization rules push payers toward electronic PA (ePA) rails. According to data from AHIP, 35% of PA requests are still submitted by fax or phone, creating submission latency that can add two or more days to the cycle before the payer even begins review.

Electronic PA submission through ePA rails dramatically reduces this latency, but coverage isn't universal, and practices that try to go fully electronic often discover that specific payer-drug combinations still require fax fallback. A complete submission solution needs to handle both channels seamlessly.

Stage 4: Payer Response - The Black Box Problem

After submission, many practices enter what may be the most frustrating phase: waiting, without visibility. The payer is reviewing the request, but the office has no real-time indication of status. If the payer has a question or needs additional documentation, they may send a fax, which may or may not be seen quickly.

In practice, this waiting period is managed by staff who call payer phone lines to check status, what the industry sometimes calls "status calls." These calls consume significant time. CAQH Index data on healthcare administrative transactions show that manual administrative interactions, such as claim or PA status inquiries, can take providers and staff 20 to 24 minutes and cost approximately $10-$12 in time. Many practices make multiple such calls or checks per prior authorization request. Across hundreds of authorizations per month, that adds up fast.

Stage 5: Denial and Appeal - The Most Avoidable Friction of All

Denials are the most disruptive event in the PA workflow and also the most preventable. According to KFF’s analysis of prior authorization denials in Medicare Advantage, a large majority (over 80%) of denied PA requests that are appealed are ultimately overturned on appeal, meaning the initial submissions often didn’t present the case optimally even though the clinical justification was sufficient.

When a denial arrives, practices must analyze the reason, gather additional evidence, write an appeal letter, and resubmit, often through the same fax-based process that caused delays in the first place. Without a structured workflow for this step, appeals are time-consuming, inconsistent, and frequently abandoned before the patient gets access to the therapy they need.

The Compounding Effect: How PA Delays Stack Into Abandonment

Each delay at one stage increases the probability of a worse outcome at the next. Think of it like a funnel with holes. The more time that passes between prescription and approval, the more patients fall out of the funnel at each stage.

How Each PA Delay Raises Abandonment Risk

Research in the Annals of Internal Medicine on primary medication non-adherence found that roughly 20% to 30 % of new prescriptions are never filled after being written, illustrating how vulnerable patients are to abandonment, when barriers such as delayed coverage decisions or poor communication exist in the period after a clinical encounter

This is how small friction points compound:

1. Day 1-2 Initiation delay: Provider sends prescription to pharmacy. Pharmacy identifies the PA requirement and faxes a PA request back to the provider's office. Staff must then look up payer-specific requirements, confirm benefit details, and queue the submission, before a single form is filled out. This handoff alone can consume 24-48 hours.
   
   

2. Day 3-4  Data gathering delay: Clinical notes must be manually reviewed and transcribed into the PA form. Incomplete submission goes out. Payer returns an additional documentation request.
   
   

3. Day 5-7 Submission and resubmission delay: Office receives fax requesting additional documentation. Staff must locate, format, and resubmit. Clock resets.
   
   

4. Day 8-12 Status uncertainty: No automated status update. Staff begins making status calls. Patient, meanwhile, has heard nothing and starts questioning whether the medication is feasible.
   
   

5. Day 13+ Denial received: Initial denial based on incomplete evidence. Appeal process begins. At this point, a meaningful percentage of patients have already abandoned.

A PA process that takes 1.5 weeks from prescription to approval isn't just slow, it's a structural threat to the start of treatment. Every day of latency is a day during which the patient can disengage, switch to a lower-friction alternative, or simply go without.

The Staff Burnout Multiplier

Beyond the patient impact, PA friction has a direct effect on the staff who manage it. According to the American Medical Association’s 2023 prior authorization physician survey, a large majority of physicians reported that prior authorization contributes somewhat or significantly to burnout, highlighting administrative burden, including PA, as a major stress point for physicians and clinical support staff.

When experienced staff burn out and leave, practices lose institutional knowledge about payer requirements and documentation nuances that is nearly impossible to replace quickly. The friction cost of staff turnover in a PA-heavy practice can dwarf the direct cost of the hours spent on authorization tasks.

High-Friction vs. Low-Friction PA Workflows: A Concrete Comparison

The difference between a high-friction and low-friction PA workflow is measurable in cycle time, staff hours, and patient outcomes. Here's a stage-by-stage comparison.

Develop Health has documented real-world customers moving from a 1.5-week prescription-to-approval cycle to approximately 20 hours, while simultaneously reducing PA handling time by 83% across their portfolio.

That's not a marginal improvement. That's a transformation of the PA workflow from a major operational liability into a routine, largely automated background process.

What Automation Removes and What It Doesn't

Automation vendors who promise to "solve prior authorization" are usually describing the elimination of operational friction, which is real and valuable, not the elimination of PA requirements themselves. Understanding the distinction protects practices from unrealistic expectations and helps them evaluate automation tools accurately.

What Automation Legitimately Removes

Modern PA automation platforms eliminate operational friction by handling the mechanical steps that don't require clinical judgment:

• Manual benefit verification: Real-time benefit checks (RTBC) through direct PBM integrations pull coverage, PA requirement status, and cost-sharing information without staff intervention.
  
  

• Form retrieval and pre-population: AI identifies the correct payer form and pre-fills it with relevant patient and clinical data extracted from the EHR, reducing manual transcription to zero.
  
  

• Submission routing: Electronic PA (ePA) rails handle submission where available; AI fax generation handles fallback cases where ePA isn't supported, ensuring 99%+ payer coverage.
  
  

• Status tracking: Automated status checks replace staff-initiated phone calls, pushing updates to the EHR task queue so providers can see PA status without leaving their workflow.
  
  

• Denial analysis and appeal generation: AI reviews denial reason codes, identifies the missing or insufficient evidence, and drafts an appeal letter using the clinical record, reducing what was a 45-90 minute manual task to a review-and-send workflow.

What Automation Cannot Remove

Automation doesn't change the payer's criteria. It doesn't bypass step therapy requirements or waive clinical documentation thresholds. If a payer requires documented failure of a first-line therapy before approving a biologic, that requirement stands, regardless of how sophisticated the submission platform is.

This distinction matters for provider expectations. Practices that adopt PA automation should expect shorter cycle times, fewer staff hours, better first-pass approval rates, and more systematic denial follow-up. They should not expect elimination of all denials or removal of payer oversight. The payer's clinical review is structural friction, it's the toll on the bridge. Automation manages the traffic jam.

Reducing PA Burden: A Practical Workflow Checklist for Provider Practices

The good news is that reducing PA friction doesn't require waiting for payer reform or policy change. The operational improvements are available today. Here's what a concrete reduction strategy looks like in practice.

Step 1: Audit Your Current PA Cycle Time

Before implementing any solution, measure where you are. Track:

• Average days from prescription to authorization decision
  
  

• Percentage of PAs submitted via fax vs. ePA
  
  

• Staff hours per PA request (initiation through completion)
  
  

• First-pass approval rate and denial rate by payer and drug
  
  

• Percentage of denials that are appealed vs. abandoned

Most practices don't have clean data on these metrics. That's itself a signal that the workflow lacks visibility, which is a core component of PA friction.

Step 2: Identify Your Highest-Friction Payer-Drug Combinations

In most practices, a small number of payer-drug combinations account for a disproportionate share of PA time and denials. Identifying those combinations allows practices to target automation or process improvement where it delivers the most value.

Look specifically for:

• High denial rate + high volume: These combinations drive the most appeal work
  
  

• Long cycle time + high abandonment: These combinations are your biggest patient access risk
  
  

• Fax-only submission: These are immediate candidates for electronic submission alternatives

Step 3: Eliminate Manual Data Entry at the Point of Submission

Manual transcription from EHR to PA form is the single most labor-intensive removable step in the PA workflow. Any automation that pre-populates PA forms from clinical data, even imperfectly, reduces staff time and error rate simultaneously.

The goal isn't perfect automation; it's reduction of the manual burden from 100% to a review-and-confirm workflow. Staff time shifts from data entry to quality review, which is both faster and more appropriate use of clinical support expertise.

Step 4: Build a Structured Denial Response Protocol

Practices that treat denials as ad-hoc events (drafting appeals from scratch case by case) are leaving significant approval rate improvement on the table. According to KFF’s analysis of Medicare Advantage prior authorization data, more than 80% of denied PA requests that are appealed are ultimately overturned, meaning the vast majority of denials are not final clinical rejections but workflow failures. The clinical case was strong enough to win on appeal, and the issue was likely in the initial submission. 

A structured denial protocol should include:

• Denial reason taxonomy: Categorize denials by type (missing documentation, step therapy not met, criteria not addressed) so patterns can be identified
  
  

• Standard appeal templates by denial type: Reduce appeal drafting from 60+ minutes to a review-and-customize workflow
  
  

• Appeal escalation triggers: Define when a case should escalate to a peer-to-peer review request vs. a written appeal vs. second-level appeal

Step 5: Move PA Status Into the EHR Workflow

Staff shouldn't have to leave the EHR to check PA status. Every portal login, every status call, every separate system a staff member has to check represents friction, both in time and in cognitive load. PA status updates that route back to the EHR task queue allow providers and staff to manage authorizations inside the workflow they're already operating in.

The Provider Outcome: What Low-Friction PA Actually Looks Like

When prior authorization friction is reduced, not theoretically, but in a live clinical environment, three things happen simultaneously: patient access improves, staff workload drops, and prescribing becomes more predictable.

Faster Access for Patients

The most direct outcome of reducing PA friction is shorter time-to-therapy. When benefit verification happens at the point of prescribing, when PA forms are pre-populated and submitted electronically, and when status updates arrive in real time, the gap between prescription and first fill shrinks dramatically.

In practice, this means patients get earlier confirmation that their medication is covered, earlier clarity on cost, and earlier access to therapy. For patients with chronic conditions or time-sensitive treatment needs, that difference is clinically meaningful — not just administratively convenient.

Less Burnout for Clinical Support Staff

Staff who spend meaningful portions of their day on fax machines, payer hold lines, and manual data transcription are doing work that doesn't leverage their training, their skills, or their capacity for patient interaction. The AMA burnout data is clear: administrative work is a top driver of staff dissatisfaction across the care continuum.

When automation removes the manual touchpoints from the PA workflow, staff time shifts toward higher-value activities, actual clinical coordination, patient communication, provider support. That shift doesn't just reduce burnout; it changes what the PA-management role looks and feels like.

More Predictable Prescribing

This is the benefit that practices most consistently underestimate: when PA friction goes down, prescribing confidence goes up. Providers who know that a PA request will be handled efficiently, tracked automatically, and followed up on denials are more willing to prescribe the therapeutically optimal medication, rather than defaulting to the path of least PA resistance.

This matters because, in high-friction environments, some providers begin to factor PA likelihood into prescribing decisions. Research on the influence of prior authorization requirements on clinical decision-making has found that providers report altering their prescribing (such as choosing alternative medications or avoiding PA-triggering therapies to minimize administrative burden), illustrating how PA requirements can shape treatment decisions. 

Frequently Asked Questions

What is prior authorization friction? 

Prior authorization friction is every manual touchpoint, redundant step, and process gap in the PA workflow that adds time and effort without adding clinical or administrative value. It includes steps like manual form entry, fax submission, status calls, and unstructured denial follow-up, all of which can be eliminated with modern automation tools without changing the underlying payer requirements.

How much time do providers spend on prior authorization each week? 

Practices spend an average of two full business days per physician per week on PA-related tasks. For a multi-physician practice, that translates to multiple full-time staff equivalents dedicated entirely to PA management.

What is the difference between structural and operational PA friction? 

Structural friction includes the payer's clinical criteria, step therapy requirements, and documentation thresholds; these are fixed requirements that automation cannot change. Operational friction includes manual data entry, fax-based submission, status calls, and reactive denial handling; these are process inefficiencies that can be eliminated entirely with the right automation platform.

How does prior authorization delay affect prescription abandonment? 

20-30% of new prescriptions are never filled, with PA delays being a major contributing factor. The longer the gap between prescription and approval confirmation, the higher the probability that a patient disengages from the therapy, particularly in specialty and high-cost drug categories.

Can automation really reduce PA cycle time from 1.5 weeks to 20 hours? 

Yes, with the right combination of real-time benefit verification, AI-powered form pre-population, electronic PA submission, and automated denial follow-up. Develop Health has documented this specific cycle time improvement with real customers. The reduction comes from eliminating operational friction at every stage, not from bypassing payer clinical review requirements.

What should providers look for when evaluating a PA automation platform? 

The most important capabilities are: 99%+ payer coverage (not just ePA, but fax fallback as well), EHR-embedded workflow so providers don't have to app-hop, real-time status visibility, AI-powered denial analysis and appeal generation, and analytics that show throughput, approval rates, and denial patterns at the payer and drug level.